Transcription Factor |
Target ORF/Genes |
References |
Evidence Code |
Evidence Experiment |
Association Type |
Strain |
Environmental Condition |
Gln3p
|
YAL068C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YAL067C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YAL064W-B
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YAL064C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YAL063C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR089W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR090C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBR091C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBR092C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR093C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR099C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR101C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR102C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YBR103W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YBR104W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR105C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR111C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR113W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR115C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR116C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR118W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YBR120C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR121C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR123C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR124W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR125C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR128C
|
PubMed
Chan TF et al., J Biol Chem, 2001 Mar 2;276(9):6463-7Chan TF et al., J Biol Chem, 2001 Mar 2;276(9):6463-7 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
S288c |
Exponential wild type and mutant yeast cultures were treated with 200 nM rapamycin |
YBR132C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR137W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBR144C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR145W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR147W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR148W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR157C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YBR158W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YBR160W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR162W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR164C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR169C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR171W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBR172C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR174C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR177C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBR182C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR184W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR185C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR187W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR189W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR190W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR191W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR196C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR197C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR208C
|
PubMed
Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
AM100 |
Minimal glucose proline medium |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64 |
Direct |
ChIP |
N/A |
S288c |
3-aminotriazole |
PubMed
Zhao X et al., Appl Environ Microbiol, 2014 Jan;80(1):392-8Zhao X et al., Appl Environ Microbiol, 2014 Jan;80(1):392-8 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Gln3p with S344A S347A S355A mutations or/and Gln3p with truncation of the exact C-terminal NLRS YNB medium supplemented with glutamine (10 mmol/liter). wt S. cerevisiae CEN PK2 strain was used as the control. |
PubMed
Zhang P et al., J Agric Food Chem, 2018 Oct 17;66(41):10881-10889Zhang P et al., J Agric Food Chem, 2018 Oct 17;66(41):10881-10889 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
BY4741 |
DELTAgzf3 vs DELTAgzf3+overIndirect of GLN3 gene: strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
BY4741 |
wt vs wt-overexpressing truncated Gln3p1-653: Strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
BY4741 |
wt vs DELTAgzf3-overexpressing truncated Gln3p1-653: Strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
Indirect |
RT-PCR - WT vs TF mutant |
Negative |
BY4741 |
wt vs DELTAgln3-overexpressing truncated Gln3p1-653: Strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
Indirect |
RT-PCR - WT vs TF mutant |
Negative |
BY4741 |
wt vs DELTAgat1-overexpressing truncated Gln3p1-653: Strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
Indirect |
RT-PCR - WT vs TF mutant |
Negative |
BY4741 |
wt vs DELTAdal80-overexpressing truncated Gln3p1-653: Strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YBR209W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR213W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR218C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR229C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR232C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR238C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR240C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR241C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBR243C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR244W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBR248C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR249C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR250W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR251W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR256C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBR258C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR265W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR266C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR271W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR281C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR282W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR283C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR284W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR285W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR288C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR291C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR292C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR294W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR297W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR298C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR302C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL066W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCL065W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCL064C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YCL063W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YCL058C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL057C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL056C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL054W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YCL050C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCL049C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YCL045C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL042W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YCL031C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YCL030C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64 |
Direct |
ChIP |
N/A |
S288c |
3-aminotriazole |
YCL027W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCL026C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL025C
|
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Abdel-Sater F et al., Genetics, 2004 Apr;166(4):1727-39Abdel-Sater F et al., Genetics, 2004 Apr;166(4):1727-39 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
induction by phenylalanine in cells grown in urea minimal medium |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL024W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL018W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCL017C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL010C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL009C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCL008C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL001W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YCR001W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR002C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR003W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR005C
|
PubMed
Rubio-Texeira M, FEBS Lett, 2007 Feb 6;581(3):541-50Rubio-Texeira M, FEBS Lett, 2007 Feb 6;581(3):541-50 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
CKY835 |
Cells grown at 24 .C in minimal medium with ammonia as nitrogen source |
Indirect |
LacZ - WT vs TF mutant |
Negative |
CKY835 |
Cells grown at 24 .C in minimal medium with glutamate as nitrogen source |
Indirect |
LacZ - WT vs TF mutant |
Negative |
CKY835 |
Cells grown at 24 .C in minimal medium with glutamine as nitrogen source |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YCR006C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR012W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCR013C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCR018C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR018C-A
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YCR019W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YCR021C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR023C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR028C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YCR040W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCR041W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YCR049C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR050C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR053W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR057C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR064C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YCR065W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YCR068W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR075C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCR077C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCR082W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YCR084C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YCR085W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR087C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR089W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR092C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR096C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR097W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YCR097W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YCR098C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR099C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR100C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR101C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCR102C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YCR104W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YCR105W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YCR106W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL248W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL247W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL243C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL242W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL241W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL238C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL237W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YDL229W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDL227C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL225W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL222C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL221W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL218W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL215C
|
PubMed
Coschigano PW et al., Mol Cell Biol, 1991 Feb;11(2):822-32Coschigano PW et al., Mol Cell Biol, 1991 Feb;11(2):822-32 |
Indirect |
Enzyme activity - WT vs TF mutant |
Positive |
S288c |
Glutamine - Yeast cells were grown with glutamine as a nitrogen source |
PubMed
Stanbrough M et al., Proc Natl Acad Sci U S A, 1995 Oct 10;92(21):9450-4Stanbrough M et al., Proc Natl Acad Sci U S A, 1995 Oct 10;92(21):9450-4 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
cells grown on glutamine as nitrogen source |
PubMed
Blinder D et al., J Bacteriol, 1995 Jul;177(14):4190-3Blinder D et al., J Bacteriol, 1995 Jul;177(14):4190-3 |
N/A |
|
N/A |
S288c |
N/A |
PubMed
Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
SIGMA1278b |
Wickerham's minimal medium + proline |
PubMed
Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9 |
Direct |
EMSA |
N/A |
S288c |
in vitro |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64 |
Direct |
ChIP |
N/A |
S288c |
3-aminotriazole |
PubMed
Georis I et al., J Biol Chem, 2011 Dec 30;286(52):44897-912Georis I et al., J Biol Chem, 2011 Dec 30;286(52):44897-912 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Methionine sulfoximine |
PubMed
Rai R et al., Genetics, 2015 Nov;201(3):989-1016Rai R et al., Genetics, 2015 Nov;201(3):989-1016 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
gln3DELTAgat1DELTA cells were grown in YNB-proline medium with Gln31 –730-Myc13 or with Gln3L332D,L336D,M340D,L343D-Myc13 |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YDL214C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL211C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL210W
|
PubMed
Talibi D et al., Nucleic Acids Res, 1995 Feb 25;23(4):550-7Talibi D et al., Nucleic Acids Res, 1995 Feb 25;23(4):550-7 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
minimal proline medium (0,1% proline) + 0,1% GABA |
PubMed
Coffman JA et al., Mol Cell Biol, 1996 Mar;16(3):847-58Coffman JA et al., Mol Cell Biol, 1996 Mar;16(3):847-58 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium + proline |
PubMed
Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9 |
Direct |
EMSA |
N/A |
S288c |
in vitro |
PubMed
Garcia SC et al., FEMS Microbiol Lett, 2000 Mar 15;184(2):219-24Garcia SC et al., FEMS Microbiol Lett, 2000 Mar 15;184(2):219-24 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
Minimal proline medium 2 (MPM2 -in 1 l it contained 0.7 g MgSO4W7H2O, 1 g KH2PO4, 0.4 g CaCl2.2H20, 0.5 g NaCl, 1 g K2SO4, 10.5 g citric acidWH2O, 10 ml vitamin solution (250 mg D-biotin, 100 mg thiamineWHCl, 1 g myo-inositol, 200 mg calcium pantothenate and 100 mg pyridoxineWHCl per liter) and 1 ml of trace metal solution (10 mg H3BO3, 1 mg CuSO4W5H2O, 2 mg KI, 4 mg Na2MoO4W2H2O, 14 mg ZnSO4W7H2O |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Cardillo SB et al., Microbiology, 2012;():Cardillo SB et al., Microbiology, 2012;(): |
Direct |
ChIP |
N/A |
S288c |
Minimal Media + GABA |
PubMed
Levi CE et al., Biochem Biophys Res Commun, 2012 May 11;421(3):572-7Levi CE et al., Biochem Biophys Res Commun, 2012 May 11;421(3):572-7 |
Direct |
ChIP |
N/A |
S288c |
Exponential phase cells cultivated in minimal growth medium containing acetate and GABA |
PubMed
Palavecino-Ruiz M et al., Microbiology, 2017 Nov;163(11):1692-1701Palavecino-Ruiz M et al., Microbiology, 2017 Nov;163(11):1692-1701 |
Indirect |
LacZ - WT vs TF mutant |
Negative |
23344c |
wt and DELTAgln3DELTAgat1 cells carrying the Yep-357-UGA4-lacZ plasmid were grown on 10mM proline |
Indirect |
LacZ - WT vs TF mutant |
Negative |
30505b |
DELTAgln3 cells carrying the Yep-357-UGA4-lacZ plasmid were grown on 10mM proline vs incubated with 0.1mM ɣ-aminobutyric acid (GABA) for 60 min |
Indirect |
LacZ - WT vs TF mutant |
Positive |
MPY15 |
wt and DELTAgln3DELTAgat1DELTAleu3 cells carrying the Yep-357-UGA4-lacZ plasmid were grown on 10mM proline and incubated with 0.1mM GABA for 60 min |
YDL205C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL202W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL201W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDL199C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL198C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Positive |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YDL191W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDL189W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL187C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL186W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL184C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDL183C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL171C
|
PubMed
Valenzuela L et al., J Bacteriol, 1998 Jul;180(14):3533-40Valenzuela L et al., J Bacteriol, 1998 Jul;180(14):3533-40 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
ammonium sulfate as N source |
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Ishida C et al., Mol Microbiol, 2006 Mar;59(6):1790-806Ishida C et al., Mol Microbiol, 2006 Mar;59(6):1790-806 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
S288c |
3-aminotriazole |
PubMed
Workman CT et al., Science, 2006 May 19;312(5776):1054-9Workman CT et al., Science, 2006 May 19;312(5776):1054-9 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YDL170W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Ishida C et al., Mol Microbiol, 2006 Mar;59(6):1790-806Ishida C et al., Mol Microbiol, 2006 Mar;59(6):1790-806 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
S288c |
3-aminotriazole |
PubMed
Workman CT et al., Science, 2006 May 19;312(5776):1054-9Workman CT et al., Science, 2006 May 19;312(5776):1054-9 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
EG328-1A |
PUGA3-lacZ reporter plasmid was introduced into wt cells or into cells deleted for GCN2 and GLN3. Cells were cultured in synthetic complete medium supplemented with all amino acids except histidine, treated with 3-AT or rapamycin(Rap) for 6h |
Indirect |
LacZ - WT vs TF mutant |
Positive |
EG328-1A |
PUGA3-lacZ reporter plasmid was introduced into wt cells or into cells deleted for GCN4 and GLN3. Cells were cultured in synthetic complete medium supplemented with all amino acids except histidine, treated with 3-AT or rapamycin(Rap) for 6h |
Indirect |
LacZ - WT vs TF mutant |
Positive |
EG328-1A |
PUGA3-lacZ reporter plasmid was introduced into wt cells or into cells deleted for GLN3. Cells were cultured in synthetic complete medium supplemented with all amino acids except histidine, treated with rapamycin(Rap) for 6h |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Positive |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YDL169C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL164C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL163W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL162C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL160C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL158C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL156W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL154W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL152W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL151C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL149W
|
PubMed
Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Nitrogen starvation |
YDL134C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL133C-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDL130W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL128W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDL127W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL123W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL122W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL114W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL105W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL104C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL101C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL099W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL091C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL085C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL085W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDL083C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL080C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL075W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL070W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDL067C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YDL066W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL065C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL063C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL061C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL059C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDL058W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDL057W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL055C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDL054C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL052C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDL050C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL041W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDL039C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL038C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL037C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL035C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL032W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL025C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL023C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL021W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL020C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL017W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDL016C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL014W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL011C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDL009C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL004W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDL003W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR008C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR009W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YDR010C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR011W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YDR012W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR013W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR021W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR022C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR027C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR029W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR030C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Workman CT et al., Science, 2006 May 19;312(5776):1054-9Workman CT et al., Science, 2006 May 19;312(5776):1054-9 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YDR031W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Workman CT et al., Science, 2006 May 19;312(5776):1054-9Workman CT et al., Science, 2006 May 19;312(5776):1054-9 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YDR032C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR034C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR034W-B
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR035W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR037W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR039C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR040C
|
PubMed
Crespo JL et al., J Biol Chem, 2001 Sep 14;276(37):34441-4Crespo JL et al., J Biol Chem, 2001 Sep 14;276(37):34441-4 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
S288c |
Rapamycin treatment |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Hirasaki M et al., J Biosci Bioeng, 2011 Mar;111(3):249-54Hirasaki M et al., J Biosci Bioeng, 2011 Mar;111(3):249-54 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
Caffeine |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR041W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YDR043C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR044W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR047W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR056C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR057W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR064W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR065W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YDR073W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR076W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR077W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YDR086C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR087C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR090C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR092W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR094W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR096W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR101C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR106W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR107C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR112W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR113C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR114C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR115W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR119W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR123C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR125C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR127W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR131C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR133C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR136C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR139C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR143C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR144C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR149C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR151C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR152W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR154C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR156W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR157W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR158W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR164C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR165W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR173C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR174W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR179C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR179W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR180W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR183W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YDR184C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR185C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR187C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR188W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR191W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR192C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR193W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR199W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR202C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR210W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YDR213W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR214W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR216W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR217C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR218C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR221W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR223W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR225W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR228C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR230W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR234W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR237W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR241W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR242W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR243C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR250C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR253C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR256C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR263C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR272W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR273W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR274C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR276C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR277C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR278C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR281C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR283C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR285W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR290W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR294C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YDR302W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR303C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR305C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR309C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YDR312W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR322W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR322C-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR331W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR332W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR336W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR337W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR338C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR340W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR341C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR342C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR343C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR344C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR354W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR360W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR363W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR365C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR366C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR369C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR371W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR372C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YDR374C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR379W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR380W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Lee K et al., Mol Microbiol, 2013 Jun;88(6):1120-34Lee K et al., Mol Microbiol, 2013 Jun;88(6):1120-34 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
BY4741 gln3DELTA and gln3DELTAgat1DELTA cells cultured in YPD medium until early exponential phase and then treated with 0.2 microg ml−1 rapamycin (Rap) for 1 h. |
PubMed
Chen X et al., J Biotechnol, 2017;():Chen X et al., J Biotechnol, 2017;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
YS58 strain with plasmid containing GLN3 ORF of MT2 or YS58 strains cloned into SalI and SacI of ADH1 promoter and terminator cloned into Escherichia coli-Yeast shuttle vector - Overexpression of GLN3; cells grown in synthetic complete medium |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
YS58 |
wt and GLN3 (gene from MT2 strain) over-expressing strains were grown for 12, 24, 48 and 72 hours, in medium used for fermentation containing 30 g/L glucose, 0.5 g/L MgSO4·7H2O, 0.5 g/L KH2PO4, and 5 g/L L-phenylalanine (l-Phe), as a sole nitrogen source. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
YS58 |
wt and GLN3 (gene from YS58 strain) over-expressing strains were grown for 12, 24, 48 and 72 hours in medium used for fermentation containing 30 g/L glucose, 0.5 g/L MgSO4·7H2O, 0.5 g/L KH2PO4, and 5 g/L L-phenylalanine (l-Phe), as a sole nitrogen source. |
YDR384C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR399W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR402C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR405W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR408C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR417C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR418W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR421W
|
PubMed
Lee K et al., Mol Microbiol, 2013 Jun;88(6):1120-34Lee K et al., Mol Microbiol, 2013 Jun;88(6):1120-34 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
BY4741 gln3DELTA and gln3DELTAgat1DELTA cells cultured in YPD medium until early exponential phase and then treated with 0.2 microg ml−1 rapamycin (Rap) for 1 h. |
PubMed
Chen X et al., J Biotechnol, 2017;():Chen X et al., J Biotechnol, 2017;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
YS58 strain with plasmid containing GLN3 ORF of MT2 or YS58 strains cloned into SalI and SacI of ADH1 promoter and terminator cloned into Escherichia coli-Yeast shuttle vector - Overexpression of GLN3; cells grown in synthetic complete medium |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
YS58 |
wt and GLN3 (gene from MT2 strain) over-expressing strains were grown for 12, 24, 48 and 72 hours, in medium used for fermentation containing 30 g/L glucose, 0.5 g/L MgSO4·7H2O, 0.5 g/L KH2PO4, and 5 g/L L-phenylalanine (l-Phe), as a sole nitrogen source. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
YS58 |
wt and GLN3 (gene from YS58 strain) over-expressing strains were grown for 12, 24, 48 and 72 hours in medium used for fermentation containing 30 g/L glucose, 0.5 g/L MgSO4·7H2O, 0.5 g/L KH2PO4, and 5 g/L L-phenylalanine (l-Phe), as a sole nitrogen source. |
YDR424C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR425W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR431W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR437W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR438W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR445C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR446W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR448W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR449C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR452W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR453C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR455C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR460W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR461W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR465C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR467C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR471W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR475C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR481C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR487C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YDR496C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR497C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR498C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR500C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR501W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR502C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YDR506C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR508C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YDR510W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YDR511W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR512C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR514C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR516C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR522C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR523C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YDR525W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YDR525W-A
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YDR526C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR528W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR531W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR532C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR534C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR536W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR537C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR538W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR541C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR543C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR544C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YEL074W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL071W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YEL065W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL064C
|
PubMed
Sato A et al., Biosci Biotechnol Biochem, 2021 Feb 24;85(3):587-599Sato A et al., Biosci Biotechnol Biochem, 2021 Feb 24;85(3):587-599 |
Indirect |
RT-PCR - WT vs TF double mutant |
Positive |
X2180-1B |
Nitrogen starved cells (Cells were grown in YPD medium to an early logarithmic phase. For nitrogen starvation, cells were washed once and further cultured for 6 h in SD-N ((0.17% yeast nitrogen base without amino acids and ammonium sulfate, and 2% glucose)). |
YEL063C
|
PubMed
Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
SIGMA1278b |
Wickerham's minimal medium + proline |
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL060C
|
PubMed
Coffman JA et al., J Bacteriol, 1997 Sep;179(17):5609-13Coffman JA et al., J Bacteriol, 1997 Sep;179(17):5609-13 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Minimal medium + glutamine |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Minimal medium + proline |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YEL059C-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YEL054C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL052W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YEL050C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL048C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL046C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YEL044W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YEL036C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YEL035C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YEL034W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YEL033W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL026W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL023C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL021W
|
PubMed
Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
AM100 |
Minimal glucose proline medium |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL019C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YEL014C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL010W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YEL009C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
EG328-1A |
GCN4-lacZ reporter plasmid (GCN4-uORF-lacZ) was introduced into wt cells vs cells deleted for GLN3andGCN2. Cells were treated with 3-AT |
Indirect |
LacZ - WT vs TF mutant |
Positive |
EG328-1A |
GCN4-lacZ reporter plasmid (GCN4-uORF-lacZ) was introduced into wt cells vs cells deleted for GLN3 or GLN3andGCN2. Cells were treated with rapamicin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YEL008W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YEL007W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YEL005C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YEL004W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YEL003W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER001W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YER002W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YER003C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER005W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YER007C-A
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YER009W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER011W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER016W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER018C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER019C-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YER022W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER024W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER026C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YER036C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YER037W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YER038C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER039C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER040W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Chen X et al., J Biotechnol, 2017;():Chen X et al., J Biotechnol, 2017;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
YS58 strain with plasmid containing GLN3 ORF of MT2 or YS58 strains cloned into SalI and SacI of ADH1 promoter and terminator cloned into Escherichia coli-Yeast shuttle vector - Overexpression of GLN3; cells grown in synthetic complete medium |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
YS58 |
wt and GLN3 (gene from MT2 strain) over-expressing strains were grown for 12, 24, 48 and 72 hours, in medium used for fermentation containing 30 g/L glucose, 0.5 g/L MgSO4·7H2O, 0.5 g/L KH2PO4, and 5 g/L L-phenylalanine (l-Phe), as a sole nitrogen source. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
YS58 |
wt and GLN3 (gene from YS58 strain) over-expressing strains were grown for 12, 24, 48 and 72 hours in medium used for fermentation containing 30 g/L glucose, 0.5 g/L MgSO4·7H2O, 0.5 g/L KH2PO4, and 5 g/L L-phenylalanine (l-Phe), as a sole nitrogen source. |
YER041W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER044C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER052C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER055C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YER056C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YER056C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER058W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER060W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER060W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER061C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER064C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER065C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER067W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER069W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER070W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YER073W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER074W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER076C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YER086W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER087C-B
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER089C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER090W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER091C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YER091C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER093C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER095W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YER097W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER103W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER109C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER113C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER119C
|
PubMed
Sato A et al., Biosci Biotechnol Biochem, 2021 Feb 24;85(3):587-599Sato A et al., Biosci Biotechnol Biochem, 2021 Feb 24;85(3):587-599 |
Indirect |
RT-PCR - WT vs TF double mutant |
Positive |
X2180-1B |
Nitrogen starved cells (Cells were grown in YPD medium to an early logarithmic phase. For nitrogen starvation, cells were washed once and further cultured for 6 h in SD-N ((0.17% yeast nitrogen base without amino acids and ammonium sulfate, and 2% glucose)). |
YER120W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YER124C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YER128W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER131W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER135C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER137C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER146W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER152C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER153C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER154W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YER156C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YER174C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER175C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER176W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER179W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER181C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER182W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER184C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YER185W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER187W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER188W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER189W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YER190W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YFL068W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL067W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL062W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YFL057C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL056C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFL053W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL052W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL051C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL046W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFL042C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL040W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL034C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL032W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL031W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFL030W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFL028C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL026W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YFL023W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YFL022C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YFL021W
|
PubMed
Coffman JA et al., J Bacteriol, 1997 Jun;179(11):3416-29Coffman JA et al., J Bacteriol, 1997 Jun;179(11):3416-29 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
TCY1 |
Minimal medium + proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Georis I et al., Mol Cell Biol, 2009 Jul;29(13):3803-15Georis I et al., Mol Cell Biol, 2009 Jul;29(13):3803-15 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
proline |
PubMed
Georis I et al., J Biol Chem, 2011 Dec 30;286(52):44897-912Georis I et al., J Biol Chem, 2011 Dec 30;286(52):44897-912 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Methionine sulfoximine |
PubMed
Georis I et al., RNA Biol, 2015;12(8):824-37Georis I et al., RNA Biol, 2015;12(8):824-37 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
wt (TB50) vs gln3DELTA (FV005) mutant, cells grown in YNB medium with proline (Pro) or treated with ammonium and methionine sulfoximine (Am. C Msx); GAT1 expression was assayed using 7 pairs of primers along the open reading frame as shown on the insert |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YFL017W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL016C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFL014W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YFL012W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFL010W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFL008W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFL003C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFR005C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YFR007W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YFR008W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YFR011C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFR017C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFR018C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFR020W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YFR022W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YFR023W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFR025C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YFR026C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFR030W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFR031C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFR032C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFR032C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YFR034C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFR035C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YFR037C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YFR041C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFR042W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFR047C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFR053C
|
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Positive |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YFR054C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YFR056C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFR055W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YFR057W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL263W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL262W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL261C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL260W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL259W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL258W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL256W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL255W
|
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YGL254W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YGL253W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL252C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL247W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL241W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL239C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL237C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL236C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL234W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL232W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL230C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL226W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGL224C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL222C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL218W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL217C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL215W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL214W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL210W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL209W
|
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Positive |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YGL208W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL204C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL203C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL202W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL198W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL194C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL193C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL192W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL191W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGL189C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL188C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL184C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL183C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL182C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL180W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Nitrogen starvation |
YGL179C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL175C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL172W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL170C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL168W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL154C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL148W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL147C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL145W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL138C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL135W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YGL133W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL132W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL127C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL125W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL123W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL121C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL118C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL117W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL116W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL114W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL112C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL110C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL109W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL105W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL103W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL102C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL099W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL095C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGL090W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL089C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL087C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGL086W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL078C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL076C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL074C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL069C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL068W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL066W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL063W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YGL062W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YGL061C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL059W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL052W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL050W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL042C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL039W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL036W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL034C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL033W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGL032C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGL031C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL028C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGL026C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL024W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL015C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGL012W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGL009C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGL008C
|
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YGL007W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YGL001C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YGR001C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR004W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR005C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR006W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR011W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR012W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR019W
|
PubMed
Talibi D et al., Nucleic Acids Res, 1995 Feb 25;23(4):550-7Talibi D et al., Nucleic Acids Res, 1995 Feb 25;23(4):550-7 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
minimal proline medium (0,1% proline) + 0,1% GABA |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
LacZ - WT vs TF mutant |
Negative |
EG328-1A |
yeast cells deleted for GCN4 and GLN3 were transformed with a plasmid encoding a lacZ reporter gene fused to the UGA1 promoter. Cells were cultured in synthetic medium containing ammonia as the nitrogen source and then switched to synthetic medium containing 10 mM GABA as the nitrogen source for 6 h |
Indirect |
LacZ - WT vs TF mutant |
Negative |
EG328-1A |
yeast cells deleted for GLN3 were transformed with a plasmid encoding a lacZ reporter gene fused to the UGA1 promoter. Cells were cultured in synthetic medium containing ammonia as the nitrogen source and then switched to synthetic medium containing 10 mM GABA as the nitrogen source for 6 h |
PubMed
Cardillo SB et al., Microbiology, 2012;():Cardillo SB et al., Microbiology, 2012;(): |
Direct |
ChIP |
N/A |
S288c |
Minimal Media + GABA |
YGR021W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR022C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR023W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR026W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YGR029W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR030C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR035C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR036C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YGR037C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR039W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR040W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR054W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR055W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR061C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR065C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR079W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR084C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR085C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR086C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR087C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR105W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR108W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR109C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR110W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR114C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR115C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR121C
|
PubMed
Marini AM et al., Mol Cell Biol, 1997 Aug;17(8):4282-93Marini AM et al., Mol Cell Biol, 1997 Aug;17(8):4282-93 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
0,1% Glutamine (nitrogen source) |
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YGR122C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR123C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR124W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR128C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR137W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR138C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR139W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR140W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR141W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR142W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR145W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR146C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR148C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR150C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR151C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR152C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR154C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR155W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR157W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR161C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Positive |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YGR164W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR165W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR168C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR173W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR177C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR180C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR181W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR182C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR183C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YGR185C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR187C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR190C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR192C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YGR196C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR204W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR206W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR210C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR211W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR212W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR214W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR215W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR219W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR222W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR226C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR228W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR234W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YGR236C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR239C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR242W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR243W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR247W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR250C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR254W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR256W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR259C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR265W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR267C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR268C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR269W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR273C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR274C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR275W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR280C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YGR283C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR284C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR285C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR286C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YGR288W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR289C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR291C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR293C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHL050C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHL048W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHL047C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHL045W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHL041W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHL036W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHL033C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YHL032C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHL030W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHL029C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YHL028W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YHL022C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHL021C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHL018W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHL016C
|
PubMed
ElBerry HM et al., J Bacteriol, 1993 Aug;175(15):4688-98ElBerry HM et al., J Bacteriol, 1993 Aug;175(15):4688-98 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
SIGMA1278b |
Wickerham's minimal medium + proline |
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Zhao X et al., Appl Environ Microbiol, 2014 Jan;80(1):392-8Zhao X et al., Appl Environ Microbiol, 2014 Jan;80(1):392-8 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Gln3p with S344A S347A S355A mutations or/and Gln3p with truncation of the exact C-terminal NLRS YNB medium supplemented with glutamine (10 mmol/liter). wt S. cerevisiae CEN PK2 strain was used as the control. |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
PubMed
Zhang P et al., J Agric Food Chem, 2018 Oct 17;66(41):10881-10889Zhang P et al., J Agric Food Chem, 2018 Oct 17;66(41):10881-10889 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
BY4741 |
DELTAgzf3 vs DELTAgzf3+overIndirect of GLN3 gene: strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
BY4741 |
wt vs wt-overexpressing truncated Gln3p1-653: Strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
BY4741 |
wt vs DELTAgzf3-overexpressing truncated Gln3p1-653: Strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
BY4741 |
wt vs DELTAgln3-overexpressing truncated Gln3p1-653: Strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
BY4741 |
wt vs DELTAgat1-overexpressing truncated Gln3p1-653: Strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
BY4741 |
wt vs DELTAdal80-overexpressing truncated Gln3p1-653: Strains were first grown in YNB + ammonium sulfate medium, supplemented with 25 mg/L leucine, 25 mg/L histidine, and 25 mg/L methionine overnight at 30.C, then cells were diluted to A600=0.2 and transferred to YPD medium for 48h. |
YHL015W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHL012W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHL005C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHL004W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHL003C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR004C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR005C-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHR006W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR007C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YHR010W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHR011W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR014W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR018C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Positive |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YHR019C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR020W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR021C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHR021W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR022C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR025W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR026W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR029C
|
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Positive |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YHR030C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YHR032W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR033W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR037W
|
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
YHR038W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR043C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR044C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR046C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR049W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR051W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YHR052W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR053C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHR055C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHR059W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR066W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR071W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHR072W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR072W-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHR075C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR079C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR079C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR081W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHR082C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR083W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR084W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR085W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR089C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR092C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR094C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR095W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR096C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR097C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR101C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR105W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR106W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR108W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR115C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR118C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR122W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR125W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR126C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR130C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR135C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR136C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR137W
|
PubMed
Iraqui I et al., Mol Cell Biol, 1999 May;19(5):3360-71Iraqui I et al., Mol Cell Biol, 1999 May;19(5):3360-71 |
Indirect |
LacZ - WT vs TF mutant |
Negative |
S288c |
urea and tryptophan |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Lee K et al., Mol Microbiol, 2013 Jun;88(6):1120-34Lee K et al., Mol Microbiol, 2013 Jun;88(6):1120-34 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
cells cultured in YPD medium until early exponential phase and then treated with 0.2 microg ml−1 rapamycin (Rap) for 1 h. |
PubMed
Chen X et al., J Biotechnol, 2017;():Chen X et al., J Biotechnol, 2017;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
YS58 strain with plasmid containing GLN3 ORF of MT2 or YS58 strains cloned into SalI and SacI of ADH1 promoter and terminator cloned into Escherichia coli-Yeast shuttle vector - Overexpression of GLN3; cells grown in synthetic complete medium |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
YS58 |
wt and GLN3 (gene from MT2 strain) over-expressing strains were grown for 12, 24, 48 and 72 hours, in medium used for fermentation containing 30 g/L glucose, 0.5 g/L MgSO4·7H2O, 0.5 g/L KH2PO4, and 5 g/L L-phenylalanine (l-Phe), as a sole nitrogen source. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
YS58 |
wt and GLN3 (gene from YS58 strain) over-expressing strains were grown for 12, 24, 48 and 72 hours in medium used for fermentation containing 30 g/L glucose, 0.5 g/L MgSO4·7H2O, 0.5 g/L KH2PO4, and 5 g/L L-phenylalanine (l-Phe), as a sole nitrogen source. |
YHR139C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR140W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHR141C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHR142W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR143W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR143W-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YHR145C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR153C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR154W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR157W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR160C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR166C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR169W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR170W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR171W
|
PubMed
Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Nitrogen starvation |
YHR173C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR174W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YHR180W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR189W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR193C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YHR194W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YHR196W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR200W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR202W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR203C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR205W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR208W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
PubMed
González J et al., Genetics, 2017 Nov;207(3):975-991González J et al., Genetics, 2017 Nov;207(3):975-991 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
CLA11-700 |
MM medium with 2% glucose with glutamine (7 mM) |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
CLA11-700 |
MM medium with 2% glucose with valine (150 mg/liter), isoleucine (30 mg/liter) and leucine (100 mg/liter) |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
CLA11-700 |
Cells grown to OD600 0.5 on MM with 2% glucose with Glutamine (biosynthetic conditions) |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
CLA11-700 |
Cells grown to OD600 0.5 on MM with 2% glucose with VIL (valine plus isoleucine plus leucine) (catabolic conditions) |
YHR209W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR215W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YHR216W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHR217C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR218W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL177C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIL176C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL175W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL172C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YIL168W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL167W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL165C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL164C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL163C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL162W
|
PubMed
Oliveira EM et al., FEMS Yeast Res, 2005;():Oliveira EM et al., FEMS Yeast Res, 2005;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Negative |
S288c |
cells grown in sucrose-proline medium to exponential phase |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL160C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIL159W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL158W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL153W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL152W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL149C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIL148W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL146C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Nitrogen starvation |
YIL145C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL141W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL138C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YIL133C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL130W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL127C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL122W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL121W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL119C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YIL116W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL113W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL112W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL105C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL104C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL103W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL102C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL100W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YIL099W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL094C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIL093C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL092W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIL089W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL088C
|
PubMed
Sato A et al., Biosci Biotechnol Biochem, 2021 Feb 24;85(3):587-599Sato A et al., Biosci Biotechnol Biochem, 2021 Feb 24;85(3):587-599 |
Indirect |
RT-PCR - WT vs TF double mutant |
Positive |
X2180-1B |
Nitrogen starved cells (Cells were grown in YPD medium to an early logarithmic phase. For nitrogen starvation, cells were washed once and further cultured for 6 h in SD-N ((0.17% yeast nitrogen base without amino acids and ammonium sulfate, and 2% glucose)). |
YIL087C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL086C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL079C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIL074C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL072W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIL070C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL066C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YIL061C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL059C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL058W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL057C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YIL056W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YIL053W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL052C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL046W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL043C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL042C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL037C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL031W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIL028W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL027C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YIL026C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL025C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL024C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIL023C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL019W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YIL018W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL015W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YIL014C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIL012W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL009C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL009W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIL008W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL001W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIR004W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YIR005W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIR009W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YIR010W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIR013C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIR014W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIR015W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIR016W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIR017C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIR018W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIR019C
|
PubMed
Jin R et al., Mol Biol Cell, 2008 Jan;19(1):284-96Jin R et al., Mol Biol Cell, 2008 Jan;19(1):284-96 |
Indirect |
GFP - WT vs TF mutant |
Positive |
S288c |
filamentous growth inducing conditions |
YIR021W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIR027C
|
PubMed
Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
SIGMA1278b |
Wickerham's minimal medium + proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Hirasaki M et al., Gene, 2008;():Hirasaki M et al., Gene, 2008;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
YPAD + 14mM Caffeine 1h |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64 |
Direct |
ChIP |
N/A |
S288c |
3-aminotriazole |
YIR028W
|
PubMed
Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
SIGMA1278b |
Wickerham's minimal medium + proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIR029W
|
PubMed
Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
SIGMA1278b |
Wickerham's minimal medium + proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIR030C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIR031C
|
PubMed
Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
AM100 |
Minimal glucose proline medium |
PubMed
Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
SIGMA1278b |
Wickerham's minimal medium + proline |
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Rai R et al., J Biol Chem, 1999 Sep 24;274(39):28026-34Rai R et al., J Biol Chem, 1999 Sep 24;274(39):28026-34 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
media 2% glucose + 0.1 % ?-aminobutyric acid |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIR032C
|
PubMed
Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9 |
Direct |
EMSA |
N/A |
S288c |
in vitro |
PubMed
Coffman JA et al., J Bacteriol, 1997 Jun;179(11):3416-29Coffman JA et al., J Bacteriol, 1997 Jun;179(11):3416-29 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
TCY1 |
Minimal medium + proline |
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rai R et al., Genetics, 2015 Nov;201(3):989-1016Rai R et al., Genetics, 2015 Nov;201(3):989-1016 |
Direct |
EMSA |
N/A |
S288c |
32P-polynucleotide kinase–labeled oligonucleotide DAL3-5 was used as the probe for DNA binding to plasmid with wt Gln31 –730-Myc13 or with Gln3L332D,L336D,M340D,L343D-Myc13 |
YIR033W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIR034C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIR035C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YIR042C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIR043C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL225C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL223C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YJL220W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL217W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL216C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL213W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL212C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YJL207C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJL205C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL202C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL200C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL196C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJL195C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL194W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL191W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YJL190C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL189W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL188C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL184W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL182C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL181W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL180C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL177W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL175W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL173C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YJL172W
|
PubMed
Coffman JA et al., J Bacteriol, 1997 Sep;179(17):5609-13Coffman JA et al., J Bacteriol, 1997 Sep;179(17):5609-13 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Minimal medium + glutamine |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Minimal medium + proline |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL170C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL169W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL168C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL166W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL160C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL159W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YJL153C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJL152W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL149W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL148W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL144W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJL142C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL136C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL134W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YJL132W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJL122W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL120W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL116C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL110C
|
PubMed
Milias-Argeitis A et al., PLoS Comput Biol, 2016 Mar 11;12(3):e1004784Milias-Argeitis A et al., PLoS Comput Biol, 2016 Mar 11;12(3):e1004784 |
Indirect |
GFP - WT vs TF mutant |
Positive |
S288c |
Gln+Rap shift |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YJL109C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL106W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YJL105W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL096W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL028W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL026W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJL023C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YJL022W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJL020C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL019W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL015C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL007C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL006C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YJR001W
|
PubMed
Sato A et al., Biosci Biotechnol Biochem, 2021 Feb 24;85(3):587-599Sato A et al., Biosci Biotechnol Biochem, 2021 Feb 24;85(3):587-599 |
Indirect |
RT-PCR - WT vs TF double mutant |
Positive |
X2180-1B |
Nitrogen starved cells (Cells were grown in YPD medium to an early logarithmic phase. For nitrogen starvation, cells were washed once and further cultured for 6 h in SD-N ((0.17% yeast nitrogen base without amino acids and ammonium sulfate, and 2% glucose)). |
YJR004C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YJR006W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YJR008W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR009C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YJR015W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YJR016C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR017C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR020W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR021C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR023C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR025C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJR034W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR035W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR038C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR040W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YJR045C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR049C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR056C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR063W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR067C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR071W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR078W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR079W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR085C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJR087W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR090C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR094W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR100C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YJR101W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR103W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJR108W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR109C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR110W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR111C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR112W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR113C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YJR115W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YJR116W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YJR117W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR119C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR120W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR123W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR124C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YJR128W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR130C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR131W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR133W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR135W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJR137C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR145C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YJR146W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YJR147W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YJR148W
|
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
González J et al., Genetics, 2017 Nov;207(3):975-991González J et al., Genetics, 2017 Nov;207(3):975-991 |
Direct |
ChIP |
N/A |
CLA11-701 |
MM medium with 2% glucose with glutamine (7 mM) |
Direct |
ChIP |
Positive |
CLA11-701 |
MM medium with 2% glucose with valine (150 mg/liter), isoleucine (30 mg/liter) and leucine (100 mg/liter) |
Direct |
ChIP |
N/A |
CLA11-700 |
Cells grown to OD600 0.5 on MM with 2% glucose with VIL (valine plus isoleucine plus leucine) (catabolic conditions) |
Direct |
ChIP |
N/A |
CLA11-700 |
Cells grown to OD600 0.5 on MM with 2% glucose with GABA |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YJR150C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR152W
|
PubMed
Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
AM100 |
Minimal glucose proline medium |
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Hirasaki M et al., Gene, 2008;():Hirasaki M et al., Gene, 2008;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
YPAD + 14mM Caffeine 1h |
PubMed
Georis I et al., J Biol Chem, 2008 Apr 4;283(14):8919-29Georis I et al., J Biol Chem, 2008 Apr 4;283(14):8919-29 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
S288c |
glutamine |
PubMed
Georis I et al., Genetics, 2009 Mar;181(3):861-74Georis I et al., Genetics, 2009 Mar;181(3):861-74 |
Direct |
ChIP |
N/A |
25T0b, FV090, FV069, FV076, FV041, 03803c |
YNB-glutamine medium treated with rapamycin (0.2 microg/ml) for 30 min |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
FV022 |
YNB-glutamine medium treated with rapamycin (0.2 microg/ml) for 30 min |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Georis I et al., Mol Cell Biol, 2011 Jan;31(1):92-104Georis I et al., Mol Cell Biol, 2011 Jan;31(1):92-104 |
Direct |
ChIP |
N/A |
S288c |
Rapamycin treatment |
PubMed
Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64 |
Direct |
ChIP |
N/A |
S288c |
3-aminotriazole |
PubMed
Georis I et al., J Biol Chem, 2011 Dec 30;286(52):44897-912Georis I et al., J Biol Chem, 2011 Dec 30;286(52):44897-912 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Rapamycin treatment |
PubMed
Fayyadkazan M et al., Microbiologyopen, 2014 Jun;3(3):271-87Fayyadkazan M et al., Microbiologyopen, 2014 Jun;3(3):271-87 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
cells grown in YPD medium and then treated with rapamycin o transferred to proline medium. |
PubMed
Numamoto M et al., J Biosci Bioeng, 2015 Aug;120(2):121-7Numamoto M et al., J Biosci Bioeng, 2015 Aug;120(2):121-7 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
DELTAgln3 carrying or not a plasmid pRS316-GLN3S391D-Myc13 incubated in YPDA medium, supplemented with 5 mM caffeine for 30 min |
PubMed
Fayyad-Kazan M et al., Mol Microbiol, 2016 Jan;99(2):360-79Fayyad-Kazan M et al., Mol Microbiol, 2016 Jan;99(2):360-79 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
cells were grown in am or ammonium (1%) + glutamine (0.1% w/v) medium. |
PubMed
González J et al., Genetics, 2017 Nov;207(3):975-991González J et al., Genetics, 2017 Nov;207(3):975-991 |
Direct |
ChIP |
N/A |
CLA11-700 |
Cells grown to OD600 0.5 on MM with 2% glucose with VIL (valine plus isoleucine plus leucine) (catabolic conditions) |
Direct |
ChIP |
N/A |
CLA11-700 |
Cells grown to OD600 0.5 on MM with 2% glucose with GABA |
YJR153W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR154W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR155W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJR156C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YJR157W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR161C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJR162C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL225W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL223W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL218C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL217W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL216W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL211C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL209C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YKL207W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL202W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL201C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL198C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKL191W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL180W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL179C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKL178C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL177W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL174C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL172W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YKL169C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL165C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKL164C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL163W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL162C-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL161C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YKL157W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YKL139W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YKL138C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL137W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL128C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKL123W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL120W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YKL116C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL115C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL114C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKL111C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL106W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL103C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YKL102C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL097C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YKL096W-A
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YKL096W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL095W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL093W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL089W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YKL086W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL085W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL084W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL083W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL078W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL076C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL073W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKL069W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YKL068W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL066W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL057C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL055C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL053C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL050C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL049C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YKL043W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL040C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YKL037W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKL036C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL033W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL032C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL031W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL030W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKL029C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL023W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL018W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL015W
|
PubMed
Rai R et al., Yeast, 1995 Mar;11(3):247-60Rai R et al., Yeast, 1995 Mar;11(3):247-60 |
N/A |
|
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKL014C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKL009W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL006C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL006W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKL004W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKR002W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR012C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKR024C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR030W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR032W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR033C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR034W
|
PubMed
Soussi-Boudekou S et al., Mol Microbiol, 1997 Mar;23(6):1157-68Soussi-Boudekou S et al., Mol Microbiol, 1997 Mar;23(6):1157-68 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
SIGMA1278b |
Minimal medium + NH4+ |
Indirect |
LacZ - WT vs TF mutant |
Positive |
SIGMA1278b |
Minimal medium + proline |
PubMed
Coffman JA et al., J Bacteriol, 1997 Jun;179(11):3416-29Coffman JA et al., J Bacteriol, 1997 Jun;179(11):3416-29 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Minimal medium + glutamine |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Minimal medium + proline |
Indirect |
LacZ - WT vs TF mutant |
Positive |
TCY1 |
Minimal medium + proline |
PubMed
Georis I et al., Mol Cell Biol, 2009 Jul;29(13):3803-15Georis I et al., Mol Cell Biol, 2009 Jul;29(13):3803-15 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Exponential-phase cells cultivated in synthetic growth medium containing 0.1% proline as nitrogen source |
PubMed
Neklesa TK et al., PLoS Genet, 2009 Jun;5(6):e1000515Neklesa TK et al., PLoS Genet, 2009 Jun;5(6):e1000515 |
Indirect |
GFP - WT vs TF mutant |
Positive |
BY4743 |
15 hour growth in YPD medium containing 20 ng/mL of rapamycin |
Indirect |
GFP - WT vs TF mutant |
Positive |
BY4743 |
4 hour growth in N-free medium |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Georis I et al., J Biol Chem, 2011 Dec 30;286(52):44897-912Georis I et al., J Biol Chem, 2011 Dec 30;286(52):44897-912 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Rapamycin treatment |
PubMed
Milias-Argeitis A et al., PLoS Comput Biol, 2016 Mar 11;12(3):e1004784Milias-Argeitis A et al., PLoS Comput Biol, 2016 Mar 11;12(3):e1004784 |
Indirect |
GFP - WT vs TF mutant |
Positive |
S288c |
Pro to Gln shift |
YKR036C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKR039W
|
PubMed
Stanbrough M et al., Proc Natl Acad Sci U S A, 1995 Oct 10;92(21):9450-4Stanbrough M et al., Proc Natl Acad Sci U S A, 1995 Oct 10;92(21):9450-4 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
cells grown on glutamate as nitrogen source |
PubMed
Blinder D et al., J Bacteriol, 1995 Jul;177(14):4190-3Blinder D et al., J Bacteriol, 1995 Jul;177(14):4190-3 |
Direct |
DNA footprinting |
N/A |
S288c |
N/A |
PubMed
Stanbrough M et al., J Bacteriol, 1995 Jan;177(1):94-102Stanbrough M et al., J Bacteriol, 1995 Jan;177(1):94-102 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
glutamine/glutamate/urea as N source |
PubMed
Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
SIGMA1278b |
Wickerham's minimal medium + proline |
PubMed
Coffman JA et al., Mol Cell Biol, 1996 Mar;16(3):847-58Coffman JA et al., Mol Cell Biol, 1996 Mar;16(3):847-58 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium + proline |
PubMed
Stanbrough M et al., J Bacteriol, 1996 Apr;178(8):2465-8Stanbrough M et al., J Bacteriol, 1996 Apr;178(8):2465-8 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
glutamate as N source |
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Rubio-Texeira M, FEBS Lett, 2007 Feb 6;581(3):541-50Rubio-Texeira M, FEBS Lett, 2007 Feb 6;581(3):541-50 |
Indirect |
LacZ - WT vs TF mutant |
Negative |
CKY835 |
Cells grown at 24 .C in minimal medium with ammonia as nitrogen source |
Indirect |
LacZ - WT vs TF mutant |
Positive |
CKY835 |
Cells grown at 24 .C in minimal medium with glutamate as nitrogen source |
Indirect |
LacZ - WT vs TF mutant |
Positive |
CKY835 |
Cells grown at 24 .C in minimal medium with glutamine as nitrogen source |
PubMed
Hirasaki M et al., Gene, 2008;():Hirasaki M et al., Gene, 2008;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
YPAD + 14mM Caffeine 1h |
PubMed
Georis I et al., Genetics, 2009 Mar;181(3):861-74Georis I et al., Genetics, 2009 Mar;181(3):861-74 |
Direct |
ChIP |
N/A |
TB123, FV018, FV036, FV041 |
YNB-glutamine medium treated with rapamycin (0.2 microg/ml) for 30 min |
PubMed
Georis I et al., Mol Cell Biol, 2009 Jul;29(13):3803-15Georis I et al., Mol Cell Biol, 2009 Jul;29(13):3803-15 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Exponential-phase cells cultivated in synthetic growth medium containing 0.1% proline as nitrogen source |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Fayyadkazan M et al., Microbiologyopen, 2014 Jun;3(3):271-87Fayyadkazan M et al., Microbiologyopen, 2014 Jun;3(3):271-87 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
cells grown in YPD medium and then treated with rapamycin o transferred to proline medium. |
PubMed
Chen X et al., J Biotechnol, 2017;():Chen X et al., J Biotechnol, 2017;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
YS58 strain with plasmid containing GLN3 ORF of MT2 or YS58 strains cloned into SalI and SacI of ADH1 promoter and terminator cloned into Escherichia coli-Yeast shuttle vector - Overexpression of GLN3; cells grown in synthetic complete medium |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
YS58 |
wt and GLN3 (gene from MT2 strain) over-expressing strains were grown for 12, 24, 48 and 72 hours, in medium used for fermentation containing 30 g/L glucose, 0.5 g/L MgSO4·7H2O, 0.5 g/L KH2PO4, and 5 g/L L-phenylalanine (l-Phe), as a sole nitrogen source. |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
YS58 |
wt and GLN3 (gene from YS58 strain) over-expressing strains were grown for 12, 24, 48 and 72 hours in medium used for fermentation containing 30 g/L glucose, 0.5 g/L MgSO4·7H2O, 0.5 g/L KH2PO4, and 5 g/L L-phenylalanine (l-Phe), as a sole nitrogen source. |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YKR040C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YKR041W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YKR042W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YKR044W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKR047W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR059W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YKR061W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR064W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR069W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKR073C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKR075C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR076W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YKR077W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR080W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR081C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR083C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKR086W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YKR092C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR093W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YKR094C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR097W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKR099W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YKR102W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YKR106W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLL067C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLL065W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLL064C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL062C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL061W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLL059C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL057C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLL055W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLL052C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL048C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL046C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLL038C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL037W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLL034C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLL033W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YLL028W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLL027W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLL026W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL025W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YLL024C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL023C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLL018C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL018C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL013C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLL012W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLL011W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLL010C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLL009C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLL005C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR002C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR004C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR006C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR012C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR013W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR022C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR023C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YLR025W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR027C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR028C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR029C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR032W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR034C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR036C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR038C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR039C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR040C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR041W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR043C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR044C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR045C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR046C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR047C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR048W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR049C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR050C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR051C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR053C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR054C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR058C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR061W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR062C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR064W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR066W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR068W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR073C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR076C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR089C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR092W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR099C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR101C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR103C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR108C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR109W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR110C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR111W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR112W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR122C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR123C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR124W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR129W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR130C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR132C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR133W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR136C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR139C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR140W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR142W
|
PubMed
Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
SIGMA1278b |
Wickerham's minimal medium + proline |
PubMed
Coffman JA et al., Mol Cell Biol, 1996 Mar;16(3):847-58Coffman JA et al., Mol Cell Biol, 1996 Mar;16(3):847-58 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium + GABA |
PubMed
Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9 |
Direct |
EMSA |
N/A |
S288c |
in vitro |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Saxena D et al., Eukaryot Cell, 2003 Jun;2(3):552-9Saxena D et al., Eukaryot Cell, 2003 Jun;2(3):552-9 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
Glutamate - yeast cells were grown in minimal medium containing glutamate (Glt, 0.1%). |
PubMed
Hirasaki M et al., Gene, 2008;():Hirasaki M et al., Gene, 2008;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
YPAD + 14mM Caffeine 1h |
PubMed
Leverentz MK et al., J Biol Chem, 2009 Sep 4;284(36):24115-22Leverentz MK et al., J Biol Chem, 2009 Sep 4;284(36):24115-22 |
Direct |
ChIP |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR147C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR148W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR150W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR152C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR153C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YLR154C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR155C
|
PubMed
Bon EP et al., Appl Biochem Biotechnol, 1997;():Bon EP et al., Appl Biochem Biotechnol, 1997;(): |
N/A |
|
N/A |
S288c |
N/A |
PubMed
Oliveira EM et al., Yeast, 2003 Jan 15;20(1):31-7Oliveira EM et al., Yeast, 2003 Jan 15;20(1):31-7 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
P40-1B |
Cells grown in YNBGlu medium with 0.2% proline as the sole nitrogen source |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
P40-1B |
Nitrogen starvation; exponential cells grown in YNBGlu medium containing 0.2% proline as the sole nitrogen source washed and incubated in a 3% glucose solution for 2 h |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
P40-1B |
Nitrogen starvation; exponential cells grown in YNBGlu medium containing 0.9% ammonium sulphate or 0.2% proline as the sole nitrogen source washed and incubated in a 3% glucose solution for 2 h |
Indirect |
Northern blot - WT vs TF deletion mutant |
Positive |
FY1679-28C |
Cells grown in YNBGlu medium with 0.2% proline as the sole nitrogen source |
Indirect |
Northern blot - WT vs TF deletion mutant |
Positive |
FY1679-28C |
Nitrogen starvation; exponential cells grown in YNBGlu medium containing 0.9% ammonium sulphate or 0.2% proline as the sole nitrogen source washed and incubated in a 3% glucose solution for 2 h |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Huang YC et al., RNA, 2010 Nov;16(11):2085-93Huang YC et al., RNA, 2010 Nov;16(11):2085-93 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
S288c |
Rapamycin treatment |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
S288c |
Without NH4+ |
YLR156W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR157C
|
PubMed
Bon EP et al., Appl Biochem Biotechnol, 1997;():Bon EP et al., Appl Biochem Biotechnol, 1997;(): |
N/A |
|
N/A |
S288c |
N/A |
YLR158C
|
PubMed
Bon EP et al., Appl Biochem Biotechnol, 1997;():Bon EP et al., Appl Biochem Biotechnol, 1997;(): |
N/A |
|
N/A |
S288c |
N/A |
YLR159W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR160C
|
PubMed
Bon EP et al., Appl Biochem Biotechnol, 1997;():Bon EP et al., Appl Biochem Biotechnol, 1997;(): |
N/A |
|
N/A |
S288c |
N/A |
YLR161W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR162W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR164W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR165C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR167W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR169W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR170C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR173W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR174W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR176C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR177W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR180W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR183C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR184W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR185W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR193C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR194C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR197W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR200W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR202C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR204W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR205C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR211C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR216C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR217W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR222C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR227C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR231C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR235C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR236C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR237W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR238W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR247C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR250W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR254C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR257W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR259C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR260W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR261C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR262C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR264W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR266C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR267W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR269C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR279W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR280C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR281C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR286C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR287C-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR290C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR293C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR294C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR299W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR300W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR302C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR303W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR307W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR308W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR311C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR312C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR312W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR315W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR318W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR321C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR322W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR325C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR327C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR328W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR329W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR331C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR334C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR337C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR338W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR339C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR340W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR341W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR342W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR343W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR344W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR348C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR354C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR355C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR358C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR359W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR360W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR364W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR366W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR367W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR372W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR373C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR375W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR376C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR377C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR379W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR380W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR381W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR383W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YLR388W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR390W-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR394W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR400W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR402W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR406C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR409C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR413W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR415C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR417W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR420W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR428C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR432W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR437C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR438W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YLR439W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR444C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR445W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR448W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR449W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR452C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YLR460C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR462W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR464W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR465C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR466W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR467W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML133C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YML132W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML123C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YML116W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YML114C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YML113W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YML112W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YML105C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML104C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML101C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML100W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YML099C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML098W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YML097C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YML093W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML090W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML089C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML087C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YML084W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YML083C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML082W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML081C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YML081W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML073C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML069W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YML063W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML062C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML058W-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YML056C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML055W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YML052W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YML050W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YML047C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML042W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML037C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YML026C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML024W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML023C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YML020W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YML019W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YML018C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YML010W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YML003W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR004W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR006C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR007W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR009W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR011W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR012W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR014W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR017W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YMR019W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR031W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR037C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR040W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR042W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR043W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR044W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR052C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR058W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR061W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR062C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR063W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR069W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YMR070W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YMR074C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR075W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR075C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR078C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR081C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR082C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR083W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR084W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR085W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR086W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR086C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR088C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YMR093W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR094W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR095C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR096W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR097C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR101C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR102C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR103C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR104C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR106C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR107W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR108W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR116C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR118C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR119W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR120C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR124W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR126C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR133W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR135W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR136W
|
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
YMR138W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR140W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR141C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR142C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR143W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR146C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR153W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR153C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR155W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR158W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR159C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR171C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR172C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR173W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR175W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR178W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR179W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR181C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR182C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR186W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR187C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR188C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR191W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR193W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR193C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR194W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR194C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR195W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YMR199W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YMR201C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR206W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR209C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR215W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR222C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR225C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR228W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR230W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR244W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR245W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR251W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR251W-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR254C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR256C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR259C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR260C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR266W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR276W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR278W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YMR279C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR283C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR284W
|
PubMed
Ungar L et al., Curr Biol, 2011 Dec 20;21(24):2115-20Ungar L et al., Curr Biol, 2011 Dec 20;21(24):2115-20 |
Indirect |
Western blot - WT vs TF mutant |
Negative |
S288c |
Rapamycin treatment |
YMR285C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR287C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR290C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR290W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR292W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR300C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR303C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR304C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR306W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR306C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YMR310C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR312W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR316C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR317W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR321C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR322C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR323W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YMR324C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YMR326C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL339C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL337W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL336W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL334C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL332W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL328C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL327W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL325C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL324W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL322C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL319W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL318C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL311C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL309W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL307C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL305C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL304W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL303W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL302C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL301C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL300W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL296W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL293W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL288W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL286W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL282W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL281W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL279W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL277W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL273W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL269W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL266W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL259C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL257C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL252C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL251C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL249C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL248C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL243W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL242W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL240C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL239W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL235C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL234W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL229C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL228W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL226W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL225C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL222W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL221C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL220W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL211C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL210W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL205C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL204C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL202W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL198C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL197C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL196C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL195C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL194C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL193W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL191W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL190W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL185C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL181W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL179C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL178W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL176C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL173C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL171C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL170W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL169C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL166C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL162W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL152W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL150W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL149C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL147W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL146W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL145W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL143C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL142W
|
PubMed
Marini AM et al., Mol Cell Biol, 1997 Aug;17(8):4282-93Marini AM et al., Mol Cell Biol, 1997 Aug;17(8):4282-93 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
0,1% Glutamine (nitrogen source) |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Hirasaki M et al., Gene, 2008;():Hirasaki M et al., Gene, 2008;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
YPAD + 14mM Caffeine 1h |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Fayyadkazan M et al., Microbiologyopen, 2014 Jun;3(3):271-87Fayyadkazan M et al., Microbiologyopen, 2014 Jun;3(3):271-87 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
cells grown in YPD medium and then treated with rapamycin o transferred to proline medium. |
PubMed
Numamoto M et al., J Biosci Bioeng, 2015 Aug;120(2):121-7Numamoto M et al., J Biosci Bioeng, 2015 Aug;120(2):121-7 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
DELTAgln3 carrying or not a plasmid pRS316-GLN3S391D-Myc13 incubated in YPDA medium, supplemented with 5 mM caffeine for 30 min |
YNL141W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YNL140C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL129W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL125C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL124W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL120C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL117W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL116W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL115C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL112W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL110C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL104C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL102W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL101W
|
PubMed
Sato A et al., Biosci Biotechnol Biochem, 2021 Feb 24;85(3):587-599Sato A et al., Biosci Biotechnol Biochem, 2021 Feb 24;85(3):587-599 |
Indirect |
RT-PCR - WT vs TF double mutant |
Positive |
X2180-1B |
Cells cultured in medium containing SD + Gln (SD-N medium supplemented with 10 mM glutamine) and then further cultured for 6 hour after shifting to SD + Pro (SD-N medium supplemented with 10 mM proline) medium |
Indirect |
RT-PCR - WT vs TF double mutant |
Positive |
X2180-1B |
Nitrogen starved cells (Cells were grown in YPD medium to an early logarithmic phase. For nitrogen starvation, cells were washed once and further cultured for 6 h in SD-N ((0.17% yeast nitrogen base without amino acids and ammonium sulfate, and 2% glucose)). |
YNL095C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL090W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL089C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL086W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL084C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL082W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL081C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL078W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL077W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL070W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL069C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL067W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YNL066W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL065W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL064C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL062C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL055C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL053W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL044W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL043C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL039W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL038W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL036W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL032W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL029C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL028W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL024C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL017C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL016W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL012W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNL011C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL009W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL008C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNL007C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNL006W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL004W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNL001W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR002C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR004W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YNR006W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YNR008W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNR009W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNR012W
|
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YNR014W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNR017W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNR018W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YNR022C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR025C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR029C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNR032C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR034W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNR035C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNR040W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR044W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNR050C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNR052C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNR053C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR054C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR055C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNR056C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNR057C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR058W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR065C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR066C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNR068C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR069C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNR076W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YNR077C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL166C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL165C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL163W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOL161C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOL160W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL159C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YOL153C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL151W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL150C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL146W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOL141W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL140W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL127W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL126C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOL125W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOL124C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL123W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL122C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOL120C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL119C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL115W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL114C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL113W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOL111C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOL109W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOL108C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOL106W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL101C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOL099C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL097C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOL093W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL091W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL090W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOL086C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOL085C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL084W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL079W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL077W-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOL077C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL067C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL064C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL060C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOL058W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOL055C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL053W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL052C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOL046C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL044W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL041C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL040C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL037C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL032W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL031C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL027C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL014W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL013C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL010W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL009C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOL005C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOL003C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR003W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR007C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR008C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR010C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR012W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR015W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR018W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR020C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR022C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR024W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR027W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR028C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR029W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR030W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR031W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR032C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR034C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR038C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR041C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR043W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR049C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR050C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR055W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR063W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOR064C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR069W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR068C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR071C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR073W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR074C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR078W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR083W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR084W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR095C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR096W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR100C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR101W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR102W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR107W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR108W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR110W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR115C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YOR121C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR130C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR134W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR141C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR144C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR146W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR152C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOR153W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOR158W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR167C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR169C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR170W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR177C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR178C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR182C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR183W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR186W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR187W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR192C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR193W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR194C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR195W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR199W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR200W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR201C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR202W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64 |
Direct |
ChIP |
N/A |
S288c |
3-aminotriazole |
YOR203W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR208W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR210W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR213C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR214C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR221C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR222W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR225W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR229W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR230W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YOR234C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR235W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR236W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOR237W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR239W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR243C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR246C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOR247W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOR248W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR252W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR254C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR255W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR263C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR265W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR273C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR277C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR279C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR282W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR283W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR285W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR287C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR288C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR291W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR293W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR298W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR298C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR299W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR300W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR301W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR302W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR303W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR305W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR306C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR308C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR309C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR314W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR315W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR316C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR321W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR328W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR333C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR334W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR337W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR338W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR340C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR342C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR343C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR344C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOR345C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR348C
|
PubMed
Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
SIGMA1278b |
Wickerham's minimal medium + proline |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR349W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR351C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR353C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR359W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR372C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR375C
|
PubMed
Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73Daugherty JR et al., J Bacteriol, 1993 Jan;175(1):64-73 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
SIGMA1278b |
Wickerham's minimal medium + proline |
PubMed
Riego L et al., Biochem Biophys Res Commun, 2002 Apr 26;293(1):79-85Riego L et al., Biochem Biophys Res Commun, 2002 Apr 26;293(1):79-85 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
Minimal medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64 |
Direct |
ChIP |
N/A |
S288c |
3-aminotriazole |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOR376W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YOR377W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR378W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR379C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR382W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR383C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR384W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR388C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YOR389W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YOR390W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR392W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YOR393W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YOR394W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL281C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL279C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL273W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL269W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL268W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL267W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL265W
|
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Positive |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YPL264C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL255W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL252C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL251W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL250C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL249C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL247C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL242C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL241C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL240C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL239W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL236C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL230W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL227C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL225W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL216W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL211W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL208W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL204W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL201C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL200W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL198W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL197C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL192C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL189W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL188W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL187W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL185W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL171C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL170W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL168W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL166W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Nitrogen starvation |
YPL165C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL164C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL158C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL154C
|
PubMed
Coffman JA et al., J Bacteriol, 1997 Sep;179(17):5609-13Coffman JA et al., J Bacteriol, 1997 Sep;179(17):5609-13 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Minimal medium + glutamine |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL151C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL146C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL143W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL142C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL139C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL136W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL135W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL131W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL130W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL121C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL113C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL111W
|
PubMed
Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
AM100 |
Minimal glucose proline medium |
PubMed
Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9 |
Direct |
EMSA |
N/A |
S288c |
in vitro |
PubMed
Smart WC et al., Mol Cell Biol, 1996 Oct;16(10):5876-87Smart WC et al., Mol Cell Biol, 1996 Oct;16(10):5876-87 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium + proline |
PubMed
Dubois E et al., Mol Gen Genet, 1997 Feb 20;253(5):568-80Dubois E et al., Mol Gen Genet, 1997 Feb 20;253(5):568-80 |
Indirect |
Enzyme activity - WT vs TF mutant |
Positive |
S288c |
growth on glutamate (release of nitrogen catabolite repression) |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Positive |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YPL108W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL107W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL106C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL104W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL097W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL093W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL092W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL091W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL090C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL089C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL081W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL080C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL073C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL072W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL068C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL062W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL056C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YPL054W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL052W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL049C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL043W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPL038W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL036W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL033C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL032C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL027W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL026C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YPL025C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL024W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YPL021W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL020C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL017C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPL014W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL013C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL009C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPL001W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR001W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR002W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR005C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR007C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR012W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPR013C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPR014C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR015C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPR017C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPR020W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YPR021C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR027C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPR034W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YPR035W
|
PubMed
Coschigano PW et al., Mol Cell Biol, 1991 Feb;11(2):822-32Coschigano PW et al., Mol Cell Biol, 1991 Feb;11(2):822-32 |
Indirect |
Enzyme activity - WT vs TF mutant |
Positive |
S288c |
Glutamate - Yeast cells were grown with glutamate as a nitrogen source |
PubMed
Stanbrough M et al., Proc Natl Acad Sci U S A, 1995 Oct 10;92(21):9450-4Stanbrough M et al., Proc Natl Acad Sci U S A, 1995 Oct 10;92(21):9450-4 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
cells grown on urea as nitrogen source |
PubMed
Blinder D et al., J Bacteriol, 1995 Jul;177(14):4190-3Blinder D et al., J Bacteriol, 1995 Jul;177(14):4190-3 |
N/A |
|
N/A |
S288c |
N/A |
PubMed
Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9Cunningham TS et al., J Bacteriol, 1996 Jun;178(12):3470-9 |
Direct |
EMSA |
N/A |
S288c |
in vitro |
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YPR038W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YPR039W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR040W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPR041W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPR042C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR043W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR045C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR048W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR052C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR054W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR058W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR060C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR064W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YPR065W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YPR069C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPR074C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPR077C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR080W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YPR083W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR087W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR092W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR097W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR101W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR102C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR108W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPR111W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR119W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YPR120C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR123C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR124W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YPR126C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR130C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR136C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR137W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR138C
|
PubMed
Marini AM et al., Mol Cell Biol, 1997 Aug;17(8):4282-93Marini AM et al., Mol Cell Biol, 1997 Aug;17(8):4282-93 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
20mM Ammonium 0,1% glutamine(nitrogen source) |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YPR141C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR142C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR145W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YPR146C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR150W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR152C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR153W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR156C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR157W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR158W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR166C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR167C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR168W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR171W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR177C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR185W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR192W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR193C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR194C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR195C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR197C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPR201W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
Q0085
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Q0115
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Q0130
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAL062W
|
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Avendaño A et al., Mol Microbiol, 2005 Jul;57(1):291-305Avendaño A et al., Mol Microbiol, 2005 Jul;57(1):291-305 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
CLA-302-0 |
b-Gal activity was determined in extracts obtained from yeast cells harvested during exponential growth on 2% ethanol as carbon source and ammonium sulphate as the nitrogen source. |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6Ponomarova O et al., Cell Syst, 2017 Oct 25;5(4):345-357.e6 |
Indirect |
RNA-seq - WT vs TF mutant |
Negative |
S90 |
wt and DELTAgln3 cells were grown in YPAD medium |
YAL059W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAL054C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAL049C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YAL048C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAL047C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAL042C-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YAL040C
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
SC medium; mid-log phase |
YAL034W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAL030W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAL029C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YAL022C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YAL015C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YAL014C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YAL012W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YAL010C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YAL007C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YAL005C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YAL003W
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YAL001C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAR002C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAR015W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YAR018C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YAR029W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YAR030C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAR035W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YAR042W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YAR047C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAR050W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Ogata T, Yeast, 2012 Nov;29(11):487-94Ogata T, Yeast, 2012 Nov;29(11):487-94 |
Indirect |
LacZ - WT vs TF mutant |
Positive |
S288c |
Nitrogen starvation |
YAR053W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YAR062W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAR066W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YAR068W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAR069C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAR070C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAR071W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YAR073W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAR075W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL112C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBL109W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL108W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL107C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBL103C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL102W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBL098W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBL097W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBL095W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL092W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL086C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBL084C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBL083C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBL078C
|
PubMed
Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Nitrogen starvation |
YBL077W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL076C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBL075C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL074C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBL073W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL072C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YBL071C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL070C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL069W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL064C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBL063W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBL062W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBL053W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL048W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL044W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL043W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBL042C
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YBL039C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL035C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL032W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBL031W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL027W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL026W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL018C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL015W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL013W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL012C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBL011W
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR006W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
PubMed
Cardillo SB et al., Microbiology, 2012;():Cardillo SB et al., Microbiology, 2012;(): |
Direct |
ChIP |
N/A |
S288c |
Minimal Media + GABA |
YBR010W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR011C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR013C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR020W
|
PubMed
Fayyad-Kazan M et al., Mol Microbiol, 2016 Jan;99(2):360-79Fayyad-Kazan M et al., Mol Microbiol, 2016 Jan;99(2):360-79 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
23344c (wt) and 30505b (gln3DELTA) strains were grown in pro medium with and without cycloheximide |
YBR025C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR030W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR031W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR032W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR033W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR034C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR035C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR040W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR042C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR043C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR046C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR047W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR048W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR053C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBR062C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR064W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR067C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR068C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR069C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR070C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YBR073W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR074W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR081C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR083W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YBR085C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR088C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL091C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL089W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL088W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL086C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL079C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL077C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL075C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL074C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL073W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL072C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL071W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL069C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL063C
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YJL049W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YJL045W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL043W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL037W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL035C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL033W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL032W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR390W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YKR104W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL017W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLL016W
|
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
YPL276W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YPR204W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR219C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL074W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YCL075W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCN0005C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0045W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR161W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YDR524W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL182W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDR524C-B
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YIL154C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER188C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGL006W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCJ0004C
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCB0010W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YGR035W-A
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YGR109W-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YGR121W-A
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YNCJ0025W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCN0016C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YHL009W-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNCM0031W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL171W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YJL136W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YIL082W-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
YIR018C-A
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YNCE0011C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YDL131W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YLR264C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCC0012C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCJ0016C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YML100W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER054C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YHR015W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCD0030W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YPL060C-A
|
PubMed
Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
S288c |
YPD medium; mid-log phase |
YNCO0001C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YAL037C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCK0002C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCJ0003C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YBR056W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCO0027C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCC0006C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCO0022C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCK0009W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCG0014C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCG0015C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCP0015C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCK0020C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCC0003C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0046W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCP0021W
|
PubMed
Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 |
Direct |
Chip-on-chip |
N/A |
S288c |
YPD medium; mid-log phase |
YNCD0010C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCG0026W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCO0028W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCO0007W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCP0013C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCE0020C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCE0003W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0005C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0042C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCB0003W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0043C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCO0003C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCP0003W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0006W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCL0041C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCO0015C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0002C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCK0001W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCC0011W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCN0014W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCE0002W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCI0001W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCK0013W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCG0044C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCH0014W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0017W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0016W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0015W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0014W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0013W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0012W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0005C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCO0026W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCO0014C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCC0007C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCO0009W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCC0004C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCD0027C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCN0002C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCJ0021C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YLR159C-A
|
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |
YNCK0008W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0035C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCP0022W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCA0004W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0004C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCJ0006W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0021C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCB0018W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCC0001C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCE0012W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCJ0002C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCK0005C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCL0044W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0010W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCP0004C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YNCB0005C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0001W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0020W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCE0004C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCJ0017C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCJ0024W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0007C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCO0004C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCP0009W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCP0023W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCE0013W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCK0012C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0020W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0038W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCJ0018W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCC0005W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCK0003W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCB0013W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0009W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0014C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0016C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0009C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0013C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCJ0008W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCK0017W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0007W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCB0015W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0011W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCK0006C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0033C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0004C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCA0006C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCB0006W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0006W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0019C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCD0028W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCE0005W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0002C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCM0009C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
tS(GCU)L
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCJ0001C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCP0016W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCJ0015W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCB0011C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
ALD1
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YSC0019
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCE0007C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER038W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
YBR126W-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0018W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YER145C-A
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0028W
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
YNCL0016C
|
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 10 mM 3-AT |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 10 mM 3-AT |